Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
TMZ Plus Apatinib in Newly Diagnosed High-grade Glioma：RCT
- Status
- UNKNOWN
- Phase
- PHASE2
Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Status
- RECRUITING
- Phase
- PHASE1
Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM
- Status
- TERMINATED
- Phase
- PHASE1
DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
rhIL-7-hyFc on Increasing Lymphocyte Counts in Patients With Newly Diagnosed Non-severe Lymphopenic Gliomas Following Radiation and Temozolomide
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE1
Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas
- Status
- COMPLETED
- Phase
- PHASE1
Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)
- Status
- COMPLETED
- Phase
- PHASE2
SGT-53 in Children With Recurrent or Progressive CNS Malignancies
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1